The German daily Mittelbayerische Zeitung highlights how lifespin is using AI and NMR-based blood analysis to detect diseases early – even before symptoms occur. In the article, CEO Dr. Ali Tinazli explains how lifespin’s platform enables personalized and preventive diagnostics that are accessible and scalable.
Read the full article (in German)
More from press and media
“Proactive health management should be the new standard of care” – lifespin CEO Dr. Ali Tinazli on precision medicine
October 30, 2025
Precision medicine is changing how we think about healthcare. It is not only about treating disease but about understanding each person’s biology early enough to ...
Read More
New leadership team appointed at lifespin, strengthening go-to-market activities and accelerating growth
October 29, 2025
Regensburg, Germany – September 16, 2025 – lifespin GmbH, a frontrunner in personalized medical analysis based on metabolomics, announces the appointment of its new leadership ...
Read More
AI Blood Test Transforming the Future of Healthcare
September 24, 2025
Discover how lifespin is revolutionizing healthcare with an AI-powered blood test.With over 250,000 human metabolomic profiles and the ability to detect more than 700 diseases, ...
Read More
How can we make advanced metabolomics accessible for routine clinical use — at an affordable cost — in service of the greater good of prevention and personalized medicine?
June 3, 2025
Earlier this year at Arab Health in Dubai, Ali Tinazli spoke about our work at Lifespin GmbH and how our General Health Assessment (GHA) supports that goal. This ...
Read More
Metabolomics. Personalized diagnostics. A “check engine light” for your body.
June 3, 2025
You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share ...
Read More
Lifespin GmbH Awarded Major Grant from Bavarian Ministry for Economic Affairs for Groundbreaking OncoSpin Project
May 14, 2025
Regensburg, Germany – May 6, 2025 – Lifespin GmbH, a frontrunner in personalized medical solutions, announces securing a grant from Bavarian Ministery for Economic Affairs ...
Read More
Lifespin GmbH and HS Weihenstephan-Triesdorf Awarded Grant from Bayerische Forschungsstiftung for Pioneering Deep Health Initiative
May 9, 2025
Regensburg, Germany – May 9, 2025 – Lifespin GmbH, a leader in personalized healthcare innovation, together with Hochschule Weihenstephan-Triesdorf (HSWT), is pleased to announce the ...
Read More
Lifespin GmbH and Premier Integrated Labs
March 31, 2025
In a significant step towards advancing preventive and personalized medicine, lifespin GmbH has partnered with Premier Integrated Labs (PIL) to introduce AI-powered metabolomic testing in ...
Read More












